The Predictive Value of the Sokal and Hasford Scoring Systems in Chronic Myeloid Leukaemia in the Imatinib Era

Journal of Hematological Malignancies
doi 10.5430/jhm.v2n2p25
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Sciedu Press

Related search

Therapy of Chronic Myeloid Leukemia: Twilight of the Imatinib Era?

ISRN Oncology
2014English

Gynaecomastia in Men With Chronic Myeloid Leukaemia After Imatinib

The Lancet
Medicine
2003English

The Utility and Applicability of Chronic Myeloid Leukemia Scoring Systems for Predicting the Prognosis of Egyptian Patients on Imatinib: Retrospective Study

Journal of Leukemia
2016English

Dasatinib in the Treatment of Imatinib Refractory Chronic Myeloid Leukemia

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Long-Term Impact of Molecular Response Fluctuations in Chronic Myeloid Leukaemia Patients Treated With Imatinib

British Journal of Haematology
Hematology
2017English

Sweet Syndrome in Chronic Myeloid Leukaemia.

Postgraduate Medical Journal
Medicine
1995English

The Use of Imatinib Resistance Mutation Analysis to Direct Therapy in Philadelphia Chromosome/BCR-Abl1 Positive Chronic Myeloid Leukaemia Patients Failing Imatinib Treatment, in Patan Hospital, Nepal

British Journal of Haematology
Hematology
2017English

Modelling Predictors of Molecular Response to Frontline Imatinib for Patients With Chronic Myeloid Leukaemia

PLoS ONE
Multidisciplinary
2017English

Factors Influencing Long-Term Efficacy and Tolerability of Bosutinib in Chronic Phase Chronic Myeloid Leukaemia Resistant or Intolerant to Imatinib

British Journal of Haematology
Hematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy